Medical Center Cologne (MCC) was founded in 2000 by Robert Gorter, MD, PhD, to apply to cancer patient his expertise, research and clinic experiences over the previous four decades. More and more patients started to name his way of treating: ‘The Gorter Model.’
The Gorter Model is an inclusive therapeutic modality of treatment of cancer patient of all sorts, patients living with chronic viral infections; such as, hepatitis B & C, HIV, and patients living with degenerative diseases. This model uses immune-supportive, nontoxic therapies.
As a cancer survivor himself, Dr. Gorter developed this program after more than forty-five years of independent clinical experience. A thorough understanding of immune function, which he received from being the medical director of the Department of AIDS Epidemiology and Bio-Statistics and as an associate clinical professor at the famous AIDS ward 86 at General Hospital in San Francisco. Read more about Robert Gorter as a physician at AIDS Clinic – Ward 86 in San Francisco, California
The innovative, nontoxic cancer therapy as part of the Gorter Model is a highly individualized approach and patients are treated according to their individual needs.
Medical Center Cologne applied the Gorter Model, since 2000. The goal of the treatment is to improve the immune system (“immune restoration”). The basic elements of the Gorter Model are the integration of the therapies and protocols in a schedule designed specifically for each patient. Traditional academic (western) medicine is being combined with new therapies, which have a sound scientific basis.
There are 3 major forms of nontoxic cancer therapy included in the Gorter Model:
- the vaccination with dendritic cells;
- various forms of hyperthermia;
- The immune restoration process, which includes Viscum album (Mistletoe), infusions with thymus and spleen peptides, vitamins and trace elements and various components which patients need.
Nobel Prize awarded for the discovery of the dendritic cells
In 2011, the Nobel Prize in Physiology and Medicine was awarded to the researchers who discovered the function of the dendritic cells and the immune system in recognizing and battling cancer cells. The Prize was divided, with one half to Bruce A. Beutler and Jules A. Hoffmann for their discoveries concerning the activation of innate immunity and the other half to Ralph M. Steinman for his discovery of the dendritic cell and its role in adaptive immunity. This award demonstrates the significance of this cell type in health and disease. Read more about how the Nobel Prize winner, Ralph Steinman, used dendritic cells to treat his own cancer.
The Gorter Model and the future of the nontoxic cancer therapy using dendritic cells vaccination and various forms of hyperthermia
Over the previous fifteen years, more than 4000 patients were treated at Medical Center Cologne with the Gorter Model. Conditions that have been successfully treated include all metastasized solid tumors, such as breast, prostate, lung, brain, liver, colon and bone cancer.
Experts expect that within a few years, dendritic cell vaccinations will become an integral part of standard treatment of various forms of cancer.
“The Gorter Model promotes especially immune, nontoxic cancer therapies, where the dendritic cells play the crucial role. I think quickly now the application and the treatment with dendritic cells as a component of the immune therapy is the future, I believe almost everybody will agree. So I think with the Gorter Model, which we started more than four decades ago, we will help also mainstream medical doctors to implement and understand the function of immune restoration and other nontoxic cancer therapies.”
Robert Gorter, MD, PhD